Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: Critical review of the literature and UK experience
- 1 April 2009
- journal article
- review article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 29 (4), 887-894
- https://doi.org/10.1002/jmri.21708
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Risk for Nephrogenic Systemic Fibrosis with Gadoteridol (ProHance) in Patients Who Are on Long-Term HemodialysisClinical Journal of the American Society of Nephrology, 2008
- Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2007
- New Insights into Nephrogenic Systemic FibrosisJournal of the American Society of Nephrology, 2007
- Gadolinium Is Not the Only Trigger for Nephrogenic Systemic Fibrosis: Insights From Two Cases and Review of the Recent LiteratureAmerican Journal of Transplantation, 2007
- Nephrogenic Systemic Fibrosis, Gadolinium, and Iron MobilizationThe New England Journal of Medicine, 2007
- Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2007
- Nephrogenic Systemic FibrosisInvestigative Radiology, 2007
- Nephrogenic fibrosing dermopathy: A series in a non-Western populationJournal of the American Academy of Dermatology, 2006
- Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failureNephrology Dialysis Transplantation, 2004
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsThe Lancet, 2000